Glyburide Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Glyburide Tablet (tablet) from Sanofi-Aventis U.S. LLC with status To Be Discontinued. The shortage was first posted on 08/10/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Sanofi-Aventis U.S. LLC
- Package NDC
- 0093-9477-53
- Dosage Form
- Tablet
- Presentation
- Diabeta, Tablet, 1.25 mg (NDC 0093-9477-53)
- Initial Posting
- 08/10/2026
- Revised Date